| Literature DB >> 32548521 |
Marzieh Emami1, Rahman Bikas2, Nader Noshiranzadeh1, Anna Kozakiewicz3, Tadeusz Lis4.
Abstract
A hydrazone ligand,Entities:
Year: 2020 PMID: 32548521 PMCID: PMC7288712 DOI: 10.1021/acsomega.0c01491
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Scheme 1Synthesis of (a) Ligand (H2L) and (b) Compound [Cu(HL′)(Cl)]·CH3OH (1)
Figure 1UV–vis spectra of H2L and compound 1 in methanol.
Figure 2Molecular structure of compound 1 with the atom numbering scheme. The pink dashed line shows hydrogen bond interaction.
Selected Bond Lengths (Å) and Angles (deg) in the Crystal Structure of Compound 1
| bond | lengths (Å) | bond | angles (deg) |
|---|---|---|---|
| Cu1–O1 | 1.913(3) | O1–Cu1–N1 | 90.10(13) |
| Cu1–N1 | 1.944(3) | O1–Cu1–N3 | 171.41(13) |
| Cu1–N3 | 1.991(3) | N1–Cu1–N3 | 81.31(14) |
| Cu1–Cl1 | 2.2196(11) | O1–Cu1–Cl1 | 92.06(9) |
| N1–Cu1–Cl1 | 177.58(11) | ||
| N3–Cu1–Cl1 | 96.53(10) |
Figure 3(a) Intermolecular hydrogen bond interactions and (b) 1D polymeric chain in the crystal structure of 1.
Hydrogen Bond Interactions in the Crystal Structure of Compounds 1, T2, and T3a
| Compound | ||||
| N2–H2N···O1Mi | 0.88 | 1.85 | 2.732(5) | 176 |
| O1M–H1M···Cl1 | 0.84 | 2.80 | 3.481(3) | 140 |
| O1M–H1M···O1 | 0.84 | 2.21 | 2.893(4) | 139 |
| C1M–H1M3···O2ii | 0.98 | 2.44 | 3.372(6) | 160 |
| C16–H16···Cl1 | 0.95 | 2.76 | 3.313 (4) | 118 |
| O9–H9A···N10 | 0.82 | 2.49 | 2.900(5) | 112.2 |
| O9–H9A···O18iii | 0.82 | 2.14 | 2.879(4) | 149.2 |
| O18–H18A···O9iv | 0.82 | 2.04 | 2.833(4) | 161.2 |
| C11–H11A···N9v | 0.93 | 2.64 | 3.326(5) | 130.8 |
| C12–H12A···O15v | 0.97 | 2.61 | 3.514(5) | 154.9 |
| O15–H15A···N8vi | 0.82 | 2.09 | 2.889(4) | 164.4 |
Symmetry codes: (i) x, y – 1, z; (ii) −x + 1, −y + 1, −z + 1; (iii) x, −y + 1/2, z + 1/2; (iv) = x, y, z – 1; (v) −x – 1/2, y, z – 1/2; and (vi) x + 1/2, −y – 2, z.
Scheme 2Preparation of Silica Gel-Supported Copper(II) Catalyst (SG-1′)
Figure 4FT-IR spectra of compound 1, SG-APTS, and SG-1′.
Figure 5(a) EDS and (b) EDS mapping analysis of the heterogeneous catalyst obtained by the reaction of SG-APTS with compound 1.
Figure 6Field-emission SEM (FESEM) image of (a) SG-ATPS, (b) SG-1′, and (c) recovered SG-1′ after the catalytic reaction.
SG-1′-Catalyzed Cycloaddition Reaction: Optimization of the Catalytic Conditions for the Epoxystyrene–Azide–Phenylacetylene Cycloaddition Reactiona
| entry | catalyst (mg) | temp. | time (h:min) | yield (%) | selectivity (%) |
|---|---|---|---|---|---|
| 1 | 0 | r.t. | 8:00 | 0 | |
| 2 | 3 | r.t. | 8:00 | 30 | 100 |
| 3 | 5 | r.t. | 6:00 | 60 | 100 |
| 4 | 7.5 | r.t. | 5:00 | 90 | 100 |
| 5 | 10 | r.t. | 4:00 | 94 | 100 |
| 6 | 15 | r.t. | 3:45 | 94 | 100 |
| 7 | 20 | r.t. | 3:30 | 92 | 100 |
| 8 | 10 | 50 | 3:00 | 93 | 100 |
| 9 | 10 | 60 | 3:00 | 93 | >95 |
| 10 | 10 | 70 | 2:45 | 92 | 82 |
| 11 | 10 | 80 | 2:30 | 94 | 60 |
| 12 | 10 | 100 | 2:30 | 93 | 50 |
Reaction conditions: epoxystyrene (1 mmol), phenylacetylene (1 mmol), NaN3 (1 mmol), SG-1′, and water (2 mL).
Isolated yield.
Synthesis of β-Hydroxy-1,2,3-triazoles by Catalytic Reaction of Azide, Epoxide, and Alkyne in the Presence of a Heterogeneous Catalyst (SG-1′)a
Reaction conditions: epoxide (1 mmol), alkyne (1 mmol), NaN3 (1 mmol), SG-1′ (10 mg), and water (2 mL).
Scheme 3Structures of β-Hydroxy-1,2,3-triazoles Obtained Using Aliphathic- or Aromatic-Substituted Epoxides at (a) Low and (b) High Temperatures
Figure 7(a) Molecular structure of product T2. (b) 1D polymeric chain obtained by intermolecular hydrogen-bonding interactions in the crystal structure of T2.
Figure 8(a) Molecular structure of product T3. (b) 2D polymeric chain obtained by intermolecular hydrogen-bonding interactions in the crystal structure of T3.
Figure 9Isolated yield of β-hydroxy-1,2,3-triazole using the recovered SG-1′ catalyst.
Figure 10EDS and EDS mapping analysis of the recovered heterogeneous catalyst after the catalytic production of β-hydroxy-1,2,3-triazoles.
Crystal Data and Structure Refinement Parameters for Compounds 1, T2, and T3
| identification code | compound | ||
|---|---|---|---|
| net formula | C19H18ClCuN3O4 | C13H17N3O2 | C11H13N3O |
| formula weight (g mol–1) | 451.35 | 247.29 | 203.24 |
| 100 | 293 | 293 | |
| crystal size (mm3) | 0.06 × 0.08 × 0.18 | 0.22 × 0.08 × 0.07 | 0.61 × 0.12 × 0.09 |
| crystal shape, color | needle, dark brown | block, colorless | needle, colorless |
| crystal system | monoclinic | monoclinic | orthorhombic |
| space group | |||
| 10.822(5) | 5.7635(13) | 9.873(2) | |
| 8.919(3) | 24.996(6) | 12.958(3) | |
| 19.088(8) | 8.917(2) | 8.353(2) | |
| β (deg) | 105.07(5) | 97.92(2) | 90 |
| volume (Å3) | 1779.0(12) | 1272.4(5) | 1068.6(4) |
| 4 | 4 | 4 | |
| density (calcd) (g cm–3) | 1.685 | 1.291 | 1.263 |
| absorption coefficient (mm–1) | 1.41 | 0.09 | 0.09 |
| 924 | 528 | 432 | |
| θ range (deg) | 3.0–27.6 | 2.5–28.3 | 2.6–28.6 |
| measured reflections | 19 300 | 8569 | 6748 |
| independent reflections | 4101 | 2914 | 2431 |
| reflections
with | 2926 | 1079 | 1295 |
| index ranges | –12 → 14, –11 → 11, –24 → 24 | –7 → 7, –32 → 31, –11 → 9 | –12 → 13, –17 → 15, –10 → 10 |
| restraints/parameters | 1/257 | 0/163 | 1/137 |
| goodness of fit on | 1.07 | 0.998 | 0.956 |
| 0.130 | 0.160 | 0.057 | |
| 0.060 | 0.094 | 0.048 | |
| w | 0.157 | 0.226 | 0.087 |
| max/min electron density (e Å–3) | 0.82/–0.68 | 0.30/–0.35 | 0.14/–0.12 |